Dupixent

Generic name: dupilumab

Used for: Eczema (atopic dermatitis) · Moderate to severe asthma (eosinophilic or steroid-dependent) · Eosinophilic COPD (chronic lung disease) · Nasal polyps and allergic fungal sinusitis · Chronic hives (chronic spontaneous urticaria) · Eosinophilic esophagitis (EoE, inflamed esophagus) · Prurigo nodularis (itchy bumps on the skin) · Bullous pemphigoid (blistering skin disease) · 7 more

How do you pay?

How to pay the least

Ask for the cash price

Dupixent

Dupixent is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Dupixent’s cash price, and one or two other pharmacies too.
  2. Dupixent’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify DUPIXENT MyWay Patient Assistance Program. demonstrate a financial need with a total annual adjusted gross income of $100,000 or less Or call 1-844-387-4936.

See if you qualify 

Compare every option

Question
Brand nameDupixent
Authorized genericdupilumab
Regular genericdupilumab
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as Dupixent?
The original
–
–

Brand nameThe maker’s card

DUPIXENT MyWay Copay Card

Savings card from Sanofi / Regeneron

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $13,000 a year off your co-pay.

Sign up on dupixent.com 

Or call 1-877-311-8972.

In the maker’s words

“With the DUPIXENT MyWay Copay Card, eligible, commercially insured patients may pay as little as $0 copay per fill of DUPIXENT (maximum of $13,000 per patient per calendar year) if they meet the eligibility requirements, including:”

From the maker’s offer on dupixent.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Dupixent itself, from the same company, sold without the brand name, and usually for less. For now Dupixent is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Dupixent is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

DUPIXENT is an interleukin-4 receptor alpha antagonist indicated:

Atopic Dermatitis

for the treatment of adult and pediatric patients aged 6 months and older with moderate-to-severe AD whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. DUPIXENT can be used with or without topical corticosteroids.

Asthma

as an add-on maintenance treatment of adult and pediatric patients aged 6 years and older with moderate-to-severe asthma characterized by an eosinophilic phenotype or with oral corticosteroid dependent asthma. Limitations of Use: Not for the relief of acute bronchospasm or status asthmaticus.

Chronic Rhinosinusitis with Nasal Polyps

as an add-on maintenance treatment in adult and pediatric patients aged 12 years and older with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP).

Eosinophilic Esophagitis

for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE).

Prurigo Nodularis

for the treatment of adult patients with prurigo nodularis (PN).

Chronic Obstructive Pulmonary Disease

as an add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype. Limitations of Use: Not for the relief of acute bronchospasm.

Chronic Spontaneous Urticaria

for the treatment of adult and pediatric patients aged 2 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment.

Limitations of Use: Not indicated for other forms of urticaria.

Bullous Pemphigoid

for the treatment of adult patients with bullous pemphigoid (BP).

Allergic Fungal Rhinosinusitis

for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis (AFRS) who have a history of sino-nasal surgery.

Source: the FDA label for Dupixent (Sanofi-Aventis U.S. LLC), April 22, 2026. Full label on DailyMed 

Good to know

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/dupixent/